In vivo CD40 ligation can induce T cell-independent antitumor effects that involve macrophages

Journal of Leukocyte Biology

Volumn 79, Issue 6, 2006, Pages 1181-1192

  Lum, Hillary D ^a   Buhtoiarov, Ilia N ^a   Schmidt, Brian E ^a   Berke, Gideon ^d   Paulnock, Donna M ^b   Sondel, Paul M ^a,c   Rakhmilevich, Alexander L ^a,c,e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e University of Wisconsin Health   (United States)

Author keywords

Anti CD40 mAb; Antitumor; Tumor immunotherapy

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; SILICON DIOXIDE; CYTOKINE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; IMMUNOTHERAPY; IN VIVO STUDY; LIGATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NEUROBLASTOMA; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; A J MOUSE; ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; CANCER TRANSPLANTATION; CYTOTOXICITY; EXPERIMENTAL MELANOMA; IMMUNOLOGY; MOUSE MUTANT; NEUTROPHIL; PERITONEUM MACROPHAGE; PHYSIOLOGY; RAT; SUBCUTANEOUS TISSUE; TUMOR CELL LINE;

MURINAE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD40; CELL LINE, TUMOR; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNOTHERAPY; KILLER CELLS, NATURAL; MACROPHAGES; MACROPHAGES, PERITONEAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED A; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, SCID; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; NEUTROPHILS; RATS; SUBCUTANEOUS TISSUE; T-LYMPHOCYTES;

EID: 33746894598     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0405191     Document Type: Article

References (32)

1. van Kooten, C., Banchereau, J. (2000) CD40-CD40 ligand. J. Leukoc. Biol. 67, 2-17.
2. Ridge, J. P., Di Rosa, F., Matzinger, P. (1998) A conditioned dendritic cell can be a temporal bridge between a CD4(+) T-helper and a T-killer cell. Nature 393, 474-478.
3. Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., Heath, W. R. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393, 478-480.
4. Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., Melief, C. J. M. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483.
5. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., Alber, G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747-752.
6. French, R. R., Chan, H. T. C., Tutt, A. L., Glennie, M. J. (1999) CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat. Med. 5, 548-553.
7. Turner, J. G., Rakhmilevich, A. L., Burdelya, C., Neal, Z., Imboden, M., Sondel, P. M., Yu, H. (2001) Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells. J. Immunol. 166, 89-94.
8. Bingle, L., Brown, N. J., Lewis, C. E. (2002) The role of tumor-associated macrophages in tumor progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
9. Imaizumi, K., Kawabe, T., Ichiyama, S., Kikutani, H., Yagita, H., Shimokata, K., Hasegawa, Y. (1999) Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction. Am. J. Physiol. 277, L49-L57.
10. Buhtoiarov, I. N., Lum, H., Berke, G., Paulnock, D. M., Sondel, P. M., Rakhmilevich, A. L. (2005) CD40 ligation activates murine macrophages via an IFN-γ-dependent mechanism resulting in tumor cell destruction in vitro. J. Immunol. 174, 6013-6022.
11. Bingaman, A. W., Pearson, T. C., Larsen, C. P. (2000) The role of CD40L in T cell-dependent nitric oxide production by murine macrophages. Transpl. Immunol. 8, 195-202.
12. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Vankooten, C., Durand, I., Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272.
13. Klostergaard, J., Leroux, M. E., Hung, M. C. (1991) Cellular models of macrophage tumoricidal effector mechanisms in vitro - characterization of cytolytic responses to tumor-necrosis-factor and nitric-oxide pathways in vitro. J. Immunol. 147, 2802-2808.
14. Lode, H. N., Xiang, R., Dreier, T., Varki, N. M., Gillies, S. D., Reisfeld, R. A. (1998) Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy. Blood 91, 1706-1715.
15. Rolink, A., Melchers, F., Andersson, J. (1996) The SCID but not the RAG-2 gene product is required for S μ-S ε heavy chain class switching. Immunity 5, 319-330.
16. Imboden, M., Murphy, K. R., Rakhmilevich, A. L., Neal, Z. C., Xiang, R., Reisfeld, R. A., Gillies, S. D., Sondel, P. M. (2001) The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy. Cancer Res. 61, 1500-1507.
17. Palmblad, K., Andersson, U. (2000) Identification of rat IL-1 β, IL-2, IFN-γ and TNF-α in activated splenocytes by intracellular immunostaining. Biotech. Histochem. 75, 101-109.
18. Zheng, W. P., Zhao, Q., Zhao, X. Y., Li, B. Y., Hubank, M., Schatz, D. G., Flavell, R. A. (2004) Up-regulation of hlx in immature th cells induces IFN-γ expression. J. Immunol. 172, 114-122.
19. Rakhmilevich, A. L. (1995) Neutrophils are essential for resolution of primary and secondary infection with Listeria monocytogenes. J. Leukoc. Biol. 57, 827-831.
20. Zagozdzon, R., Golab, J., Stoklosa, T., Giermasz, A., Nowicka, D., Feleszko, W., Lasek, W., Jakobisiak, M. (1998) Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin. Int. J. Cancer 77, 720-727.
21. Macdougall, J. R., Croy, B. A., Chapeau, C., Clark, D. A. (1990) Demonstration of a splenic cytotoxic effector cell in mice of genotype Scid/Scid.Bg/Bg. Cell. Immunol. 130, 106-117.
22. Mcdyer, J. F., Goletz, T. J., Thomas, E., June, C. H., Seder, R. A. (1998) CD40 ligand CD40 stimulation regulates the production of IFN-γ from human peripheral blood mononuclear cells in an IL-12- and/or CD28-dependent manner. J. Immunol. 160, 1701-1707.
23. Grote, D., Cattaneo, R., Fielding, A. K. (2003) Neutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expression. Cancer Res. 63, 6463-6468.
24. Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C., Spriggs, M. K. (1993) CD40 expression by human monocytes - regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178, 669-674.
25. Pulaski, B. A., Smyth, M. J., Ostrand-Rosenberg, S. (2002) Interferon-γ- dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma. Cancer Res. 62, 4406-4412.
26. Buhtoiarov, I. N., Lum, H. D., Berke, G., Sondel, P. M., Rakhmilevich, A. L. (2006) Synergistic activation of macrophages via CD40 and TLR9 results in T cell independent antitumor effects. J. Immunol. 176, 309-318.
27. Van Rooijen, N., Sanders, A. (1994) Liposome-mediated depletion of macrophages - mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174, 83-93.
28. Yoshida, R., Yoneda, Y., Kuriyama, M., Kubota, T. (1999) IFN-γ- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. J. Immunol. 163, 148-154.
29. Cui, S., Reichner, J. S., Mateo, R. B., Albina, J. E. (1994) Activated murine macrophages induce apoptosis in tumor-cells through nitric-oxide- dependent or nitric-oxide-independent mechanisms. Cancer Res. 54, 2462-2467.
30. Decker, T., Lohmannmatthes, M. L., Gifford, G. E. (1987) Cell-associated tumor-necrosis-factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138, 957-962.
31. Smyth, M. J., Cretney, E., Takeda, K., Wiltrout, R. H., Sedger, L. M., Kayagaki, N., Yagita, H., Okumura, K. (2001) Tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193, 661-670.
32. Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., Godfrey, D. I. (2000) Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191, 661-668.